Coalition for Epidemic Preparedness Innovations & GAVI

Coalition for Epidemic Preparedness Innovations: The Coalition for Epidemic Preparedness Innovations (CEPI) is a key funder, committing approximately $60 million to accelerate the development of Ebola Bundibugyo vaccines, and is crucial in coordinating the global response.

GAVI: GAVI, a global vaccine alliance, committed up to $50 million to the Ebola response, contributing to the overall funding for combating the outbreak.

Coalition for Epidemic Preparedness Innovations: Funding vaccine development efforts, including the Oxford and Hilleman candidates. Its investment is critical for accelerating vaccine research.

GAVI: Making its RVSV-ZEBOV vaccine stockpile available for trials and supporting vaccine access. Its role is key in ensuring vaccine availability for the response.

Coalition for Epidemic Preparedness Innovations: The Coalition for Epidemic Preparedness Innovations (CEPI) funds vaccine development and is assessing potential Ebola vaccine candidates, aiming for a rapid response.

GAVI: GAVI>>> holds a stockpile of Ebola vaccines and has 2,000 doses already in the Democratic Republic of the Congo>>> for potential trial use.

Coalition for Epidemic Preparedness Innovations: The Coalition for Epidemic Preparedness Innovations is mentioned as a past collaborator with Altor BioScience, indicating Altor BioScience's involvement in epidemic preparedness.

GAVI: GAVI is mentioned as a past collaborator with Altor BioScience, underscoring Altor BioScience's role in global vaccine access.

Coalition for Epidemic Preparedness Innovations: CEPI is listed as a partner in the urgent coordination meeting convened by Africa CDC, indicating potential involvement in the response to the Ebola outbreak.

GAVI: GAVI is listed as a partner in the urgent coordination meeting convened by Africa CDC, indicating potential involvement in the response to the Ebola outbreak.